Your session is about to expire
← Back to Search
074-6751 Lotion for Plaque Psoriasis
N/A
Waitlist Available
Research Sponsored by Ferndale Laboratories, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 29
Awards & highlights
Summary
The primary objective of this study is to determine the efficacy and safety of 074-6751 Lotion applied twice daily for four weeks (28 days) in clinical subjects with moderate plaque psoriasis.
Eligible Conditions
- Plaque Psoriasis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 29
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 29
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline in sum of clinical signs of psoriasis (scaling, erythema, and plaque elevation) scores.
Secondary outcome measures
The proportion of subjects with improvement versus Baseline in IGA score.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 074-6751 LotionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
074-6751 Lotion
2017
N/A
~100
Find a Location
Who is running the clinical trial?
Ferndale Laboratories, Inc.Lead Sponsor
4 Previous Clinical Trials
213 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger